November 16, 2020
Ionis Pharmaceuticals retained The Chase Group to identify and secure the next member of their drug safety leadership team to support a robust and continually growing pipeline. After an extensive search, The Chase Group is proud to announce the successful placement of an Executive Director, Drug Safety Physician. Known for her strong work ethic and knowledgeable industry experience, the new Executive Director will play a pivotal role as she assumes responsibility for the clinical safety strategy of assigned projects and products, driving the proactive implementation of risk management initiatives. As the leading innovator in RNA-targeted therapeutics, Ionis Pharmaceuticals is driven by world-class scientists and business leaders whose passion to innovate is matched only by their commitment to delivering transformational medicines to patients who need them. The Chase Group is proud to continue its long-standing partnership with Ionis and continue to place industry leaders who share the company’s motivation and drive to make a difference in the lives of patients. To learn how The Chase Group can help you build your life science leadership team, contact karen@chasegroup.com.
